Dec 18 (Reuters) - Gensight Biologics SA SIGHT.PA :
* GENSIGHT BIOLOGICS SA: LUMEVOQ FIRST INJECTIONS EXPECTED
IN
JANUARY 2025
* GENSIGHT BIOLOGICS SA: DOES NOT HAVE SUFFICIENT NET
WORKING
CAPITAL TO MEET ITS OBLIGATIONS OVER NEXT 12 MONTHS BUT ONLY
UNTIL EARLY JAN 2025
* GENSIGHT BIOLOGICS SA: ADVANCED DISCUSSIONS TO SECURE
FINANCING
UNTIL FIRST EARLY ACCESS PROGRAM (AAC) PAYMENT EXPECTED IN LATE
JANUARY 2025
Source text: ID:nBw7vQJ1Ba
Further company coverage: SIGHT.PA
(((( Reuters.Briefs@thomsonreuters.com ;));))